Last reviewed · How we verify

NCT05898919

Acupuncture for Postoperative Urinary Retention After Hemorrhoidectomy: a Randomized Controlled Trial

Completed Phase 2 Last updated 10 July 2023
What this trial tests

Phase 2 trial testing Acupuncture in Postoperative Complications in 92 participants. Completed in 6 July 2023.

Timeline
1 March 2022
Primary endpoint
25 May 2023
6 July 2023

Quick facts

Lead sponsorChengdu University of Traditional Chinese Medicine
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment92
Start date1 March 2022
Primary completion25 May 2023
Estimated completion6 July 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chengdu University of Traditional Chinese Medicine

Who can join

Adults 18 to 65, any sex, with Postoperative Complications or Postoperative Urinary Retention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to examine the efficacy of acupuncture in the management of acute postoperative urinary retention. Clinical question: Is acupuncture efficacious for postoperative urinary retention after hemorrhoidectomy compared with sham acupuncture and neostigmine. Study design: The participants who undergo hemorrhoidectomy and report postoperative urinary retention will receive one session of acupuncture or sham acupuncture or one injection of 1-mg neostigmine. The primary outcome was the time to first urination after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

Other recruiting trials for Postoperative Complications

Currently open trials in the same condition.

Other Chengdu University of Traditional Chinese Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing